Table 3 Descriptive statistics for the levels of matrix metalloproteinases (MMP–2, MMP–9), their inhibitors (TIMP-1, TIMP-2) and adiponectin at three time points, i.e. before radioiodine treatment (RIT), visit 1 (V1), seven days post RIT, visit 2 (V2), and two-three months post RIT, visit 3 (V3), p-value for the Friedman ANOVA test, Group 2, n=20
Visits | Mean | Med | Min | Max | SD | SEM | p-value | |
|---|---|---|---|---|---|---|---|---|
MMP-2 [ng/ml] | V1 | 356 | 358.0 | 243.9 | 488.0 | 73.2 | 16.8 | 0.24 |
V2 | 349 | 348.8 | 221.8 | 470.3 | 63.3 | 14.9 | ||
V3 | 362 | 373.1 | 283.2 | 449.2 | 54.0 | 13.5 | ||
MMP-9 [ng/ml] | V1 | 647 | 500.0 | 220.0 | 1390.0 | 343.8 | 78.9 | 0.56 |
V2 | 584 | 500.0 | 180.0 | 1790.0 | 378.5 | 89.2 | ||
V3 | 628 | 655.0 | 180.0 | 1020.0 | 261.9 | 65.5 | ||
TIMP-1 [ng/ml] | V1 | 157 | 160.0 | 70.0 | 260.0 | 52.7 | 12.1 | 0.063 |
V2 | 173 | 170.0 | 100.0 | 260.0 | 40.8 | 9.6 | ||
V3 | 174 | 175.0 | 110.0 | 220.0 | 29.7 | 7.4 | ||
TIMP-2 [ng/ml] | V1 | 129 | 120.0 | 75.0 | 285.0 | 45.3 | 10.4 | 0.012 |
V2 | 139 | 135.0 | 95.0 | 215.0 | 36.3 | 8.6 | ||
V3 | 149 | 137.5 | 90.0 | 220.0 | 38.3 | 9.6 | ||
Adiponectin [ng/ml] | V1 | 15201 | 11890.0 | 3780.0 | 37970.0 | 8860.0 | 2032.6 | 0.0004 |
V2 | 13966 | 13020.0 | 3740.0 | 24990.0 | 6432.4 | 1516.1 | ||
V3 | 19373 | 17190.0 | 8010.0 | 38550.0 | 8657.4 | 2164.4 |